Low Dose IL-2 for Ulcerative Colitis
NCT02200445
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class
Conditions
Ulcerative Colitis
Interventions
DRUG:
Interleukin-2 (aldesleukin).
Sponsor
Scott B. Snapper, MD PHD